Alyftrek 51167-0135
Generic: Vanzacaftor, Tezacaftor, And Deutivacaftor
Product NDC
51167-0135- Manufacturer
- Vertex Pharmaceuticals Incorporated
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 20, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA218730
Need to source Alyftrek? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deutivacaftor | 50 mg/1 |
| Tezacaftor | 20 mg/1 |
| Vanzacaftor | 4 mg/1 |
Drug Class
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Chloride Channel Activation Potentiators [MoA]
Packaging Options(1)
4 BLISTER PACK in 1 CARTON (51167-135-01) / 21 TABLET, FILM COATED in 1 BLISTER PACK